689294-25-5

Basic information

• Product Name: Phenyl (5-aMino-1-Methyl-1H-pyrazol-4-yl)carbaMate, 95%
• Synonyms: Phenyl (5-aMino-1-Methyl-1H-pyrazol-4-yl)carbaMate, 95%
• CAS NO: 689294-25-5
• Molecular Formula: C₁₁H₁₂N₄O₂
• Molecular Weight: 232.23858
• Mol File: 689294-25-5.mol

Chemical Properties

• Appearance: /
• CAS DataBase Reference: Phenyl (5-aMino-1-Methyl-1H-pyrazol-4-yl)carbaMate, 95%(CAS DataBase Reference)
• NIST Chemistry Reference: Phenyl (5-aMino-1-Methyl-1H-pyrazol-4-yl)carbaMate, 95%(689294-25-5)
• EPA Substance Registry System: Phenyl (5-aMino-1-Methyl-1H-pyrazol-4-yl)carbaMate, 95%(689294-25-5)

Safety Data

• Hazardous Substances Data: 689294-25-5(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
Phenyl (5-amino-1-methyl-1H-pyrazol-4-yl) carbamate, 95% is used as a pharmaceutical intermediate for the synthesis of certain drugs. Its unique structure allows for the modification of other molecules, enabling the development of new and effective pharmaceuticals.
Used in Research and Development:
Due to its high purity level of 95%, Phenyl (5-amino-1-methyl-1H-pyrazol-4-yl) carbamate is used in research and development processes where precise control over composition is crucial. It serves as a valuable compound for exploring new chemical reactions and applications in various fields.
Used in Chemical Modification:
Phenyl (5-amino-1-methyl-1H-pyrazol-4-yl) carbamate, 95% is used for the modification of other molecules to achieve specific functions. Its phenyl group, amino group, and pyrazole ring structure provide versatility in chemical reactions, making it a valuable compound for creating new molecules with desired properties.

Upstream product

• 1885-14-9 phenyl chloroformate 
• 45514-38-3 1-methyl-1H-pyrazole-4,5-diamine 
• 20055-01-0 4,5-diamino-1-methylpyrazole sulfate 

Downstream Products

• 689293-69-4 4-(3-{2-[(tert-butoxycarbonyl)amino]ethyl}ureido)-1-methyl-5-triphenylmethylaminopyrazole 
• 689294-26-6 1-methyl-4-phenoxycarbonylamino-5-triphenylmethylaminopyrazole 

Relevant articles and documents

SOLID FORMS OF CEFTOLOZANE AND PROCESSES FOR PREPARING

The instant invention is related to a novel solid form of ceftolozane sulfate (the DMAc solvate of ceftolozane sulfate (Form 3)), compositions comprising ceftolozane sulfate DMAc solvate (Form 3), synthesis of Form 3 and an improved crystallization proces

INTERMEDIATES IN THE SYNTHESIS OF CEPHALOSPORIN COMPOUNDS

Described herein are crystalline forms of a compound of formula (ΙΙΓ), including toluene solvates ofT A TD-CLE, as well as processes for the preparation thereof and use thereof in the preparation of cephalosporin compounds such as ceftolozane. Provided he

Synthesis and SAR of novel parenteral anti-pseudomonal cephalosporins: Discovery of FR264205

We describe herein the synthesis and biological evaluation of a series of novel cephalosporins with potent activity against Pseudomonas aeruginosa. Introduction of various amino groups to the 4-position of a 3-amino-2-methylpyrazole cephalosporin 3-side c

CEPHEM COMPOUNDS

The present invention relates to a compound of the formula [I]: wherein R1 is lower alkyl or hydroxy (lower) alkyl, and R2 is hydrogen or amino protecting group, or R1 and R2 are bonded together and form lower a

CEPHEM COMPOUNDS

The present invention relates to a compound of the formula [I]: wherein R1 is lower alkyl, hydroxy(lower)alkyl or halo(lower)alkyl, and R2 is hydrogen or amino protecting group, or R1 and R2 are bonded together and form lower alkylene or lower alkenylene; R3 is hydrogen or lower alkyl; R4 is ; R5 is carboxy or protected carboxy; and R6 is amino or protected amino, or a pharmaceutically acceptable salt thereof, a process for preparing a compound of the formula [I], and a pharmaceutical composition comprising a compound of the formula [I] in admixture with a pharmaceutically acceptable carrier.